NASDAQ: CLLS
Cellectis Sa Stock Ownership - Who owns Cellectis Sa?

Insider buying vs selling

Have Cellectis Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CLLS insiders and whales buy or sell their stock.

CLLS Shareholders

What type of owners hold Cellectis Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Long Focus Capital Management LLC5.70%4,123,262$19.54MInstitution
B Group Inc4.54%3,281,501$15.55MInstitution
Macquarie Group Ltd0.31%226,875$1.08MInstitution
Citadel Advisors LLC0.31%221,959$1.05MInstitution
Morgan Stanley0.12%87,675$415.58kInstitution
Lpl Financial LLC0.12%85,147$403.60kInstitution
Millennium Management LLC0.08%57,740$273.69kInstitution
Susquehanna International Group LLP0.07%53,865$255.32kInstitution
Bnp Paribas Financial Markets0.06%41,300$195.76kInstitution
Ubs Group Ag0.04%29,299$138.88kInstitution

1 of 3

CLLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLLS11.49%0.00%
NBP15.78%0.00%
KYTX50.31%49.69%
XFOR18.48%9.14%Net SellingNet Buying
DRTS2.15%0.00%

Cellectis Sa Stock Ownership FAQ

Who owns Cellectis Sa?

Cellectis Sa (NASDAQ: CLLS) is owned by 11.49% institutional shareholders, 0.00% Cellectis Sa insiders, and 88.51% retail investors. Long Focus Capital Management LLC is the largest individual Cellectis Sa shareholder, owning 4.12M shares representing 5.70% of the company. Long Focus Capital Management LLC's Cellectis Sa shares are currently valued at $19.54M.

If you're new to stock investing, here's how to buy Cellectis Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.